Follow
anna Kuisma
anna Kuisma
Unknown affiliation
Verified email at utu.fi
Title
Cited by
Cited by
Year
Prospective evaluation of planar bone scintigraphy, SPECT, SPECT/CT, 18F-NaF PET/CT and whole body 1.5T MRI, including DWI, for the detection of bone …
I Jambor, A Kuisma, S Ramadan, R Huovinen, M Sandell, S Kajander, ...
Acta oncològica 55 (1), 59-67, 2016
2262016
In Vivo Imaging of Prostate Cancer Using [68Ga]-Labeled Bombesin Analog BAY86-7548
E Kähkönen, I Jambor, J Kemppainen, K Lehtiö, TJ Grönroos, A Kuisma, ...
Clinical cancer research 19 (19), 5434-5443, 2013
2122013
Prospective evaluation of 18F-FACBC PET/CT and PET/MRI versus multiparametric MRI in intermediate- to high-risk prostate cancer patients (FLUCIPRO trial)
I Jambor, A Kuisma, E Kähkönen, J Kemppainen, H Merisaari, O Eskola, ...
European journal of nuclear medicine and molecular imaging 45, 355-364, 2018
732018
Comparison of standardized uptake values between 99mTc-HDP SPECT/CT and 18F-NaF PET/CT in bone metastases of breast and prostate cancer
S Arvola, I Jambor, A Kuisma, J Kemppainen, S Kajander, M Seppänen, ...
EJNMMI research 9 (1), 1-9, 2019
522019
Safety, biodistribution, and radiation dosimetry of 18F-rhPSMA-7.3 in healthy adult volunteers
T Tolvanen, K Kalliokoski, S Malaspina, A Kuisma, S Lahdenpohja, ...
Journal of Nuclear Medicine 62 (5), 679-684, 2021
232021
Validation of automated magnetic resonance image segmentation for radiation therapy planning in prostate cancer
A Kuisma, I Ranta, J Keyriläinen, S Suilamo, P Wright, M Pesola, ...
Physics and imaging in radiation oncology 13, 14-20, 2020
172020
Correlation between 18F-1-amino-3-fluorocyclobutane-1-carboxylic acid (18F-fluciclovine) uptake and expression of alanine-serine-cysteine-transporter 2 (ASCT2 …
I Saarinen, I Jambor, M Kim, A Kuisma, J Kemppainen, H Merisaari, ...
EJNMMI research 9, 1-11, 2019
162019
Kinetic analysis and optimisation of 18F-rhPSMA-7.3 PET imaging of prostate cancer
S Malaspina, V Oikonen, A Kuisma, O Ettala, K Mattila, PJ Boström, ...
European Journal of Nuclear Medicine and Molecular Imaging 48, 3723-3731, 2021
132021
Uptake of 18F-rhPSMA-7.3 in Positron Emission Tomography Imaging of Prostate Cancer: A Phase 1 Proof-of-Concept Study
S Malaspina, P Taimen, M Kallajoki, V Oikonen, A Kuisma, O Ettala, ...
Cancer Biotherapy & Radiopharmaceuticals 37 (3), 205-213, 2022
92022
Prospective evaluation of planar bone scintigraphy, SPECT/CT, 18F NAF PET/CT and whole body 1.5 T MRI for detection of bone metastases in high risk breast and prostate cancer …
AK Kuisma, I Jambor, R Huovinen, M Sandell
Annals of Oncology 23, ix384, 2012
62012
Comparison of standardized uptake values between 99mTc-HDP SPECT/CT and 18F-NaF PET/CT in bone metastases of breast and prostate cancer. EJNMMI Res. 2019; 9 (1): 6
S Arvola, I Jambor, A Kuisma, J Kemppainen, S Kajander, M Seppänen
Přejít k původnímu zdroji... Přejít na PubMed, 2011
52011
Prediction of prostate cancer aggressiveness using 18F-Fluciclovine (FACBC) PET and multisequence multiparametric MRI
P Movahedi, H Merisaari, IM Perez, P Taimen, J Kemppainen, A Kuisma, ...
Scientific Reports 10 (1), 9407, 2020
42020
Comparison of reprojected bone SPECT/CT and planar bone scintigraphy for the detection of bone metastases in breast and prostate cancer
S Arvola, M Seppänen, S Malaspina, S Mätzke, J Raiko, KL Timonen, ...
Nuclear Medicine Communications 43 (5), 510-517, 2022
32022
Detection of prostate cancer using 68Ga-labelled bombesin analogue BAY 86-7548 in patients undergoing radical prostatectomy
H Minn, E Kahkonen, I Jambor, J Kemppainen, K Lehtio, A Kuisma, ...
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 39, S255-S255, 2012
32012
Long-term outcome of biologically guided dose-escalated radiotherapy of localized prostate cancer
A Kuisma, P Wright, S Suilamo, J Seppälä, M Koivisto, P Lindholm, ...
Acta Oncologica 61 (1), 97-103, 2022
22022
Prospective evaluation of planar bone scintigraphy, SPECT/CT, 18F NaF PET/CT and whole body 1.5 T MRI for detection of bone metastases in high risk breast and prostate cancer …
I Jambor, A Kuisma, R Huovinen, M Sandell, J Auren, S Kajander, ...
Acta Oncologica 55 (1), 59-67, 2013
22013
Kinetic Modelling of F-18-rhPSMA-7.3 Uptake in PET Imaging of Prostate Cancer
S Malaspina, V Oikonen, A Kuisma, O Ettala, K Mattila, PJ Bostrom, ...
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 47 (SUPPL 1 …, 2020
12020
Prediction of prostate cancer aggressiveness using ¹⁸F-Fluciclovine (FACBC) PET and multisequence multiparametric MRI
P Movahedi, H Merisaari, IM Perez, P Taimen, J Kemppainen, A Kuisma, ...
Springer Nature, 2020
2020
Prediction of prostate cancer aggressiveness using 18 F-Fluciclovine (FACBC) PET and multisequence multiparametric MRI
M Parisa, M Harri, IM Perez, T Pekka, K Jukka, A Kuisma, E Olli, T Jarmo, ...
Scientific Reports (Nature Publisher Group), 2020
2020
ORIGINAL RESEARCH Open Access
I Saarinen, I Jambor, M Kim, A Kuisma, J Kemppainen, H Merisaari, ...
2019
The system can't perform the operation now. Try again later.
Articles 1–20